/Investor DB

FREEFLOW — Full Portfolio

35 tracked investments · listed companies and verified rows first

3Laws Robotics3lawsrobotics.ioJun 2022

Pasadena, US

Andrew Singletary(Cofounder)Aaron Ames(Director)Thomas Gurriet(Executive Officer, Director)in

Co-investorsEmbark VenturesTenOneTen Ventures

Aralez Bioaralezbio.comin

Aralez Bio produces noncanonical amino acids using biocatalysis, including compounds that add rigidity to peptide backbones and increase enzyme resistance.

BiotechCleantechClimate TechDeep TechNew MaterialsBerkeley, US

Tina Boville(Co-founder & CEO)inDavid Romney(Co-founder)inFrances Arnold(Co-founder / Scientific Founder)

Co-investorsAstiaFifty YearsGood Growth CapitalISVJuniperPaladin Capital Group+2 more

Biomarqbiomarq.health

Biomarq Health develops a wearable, injectable multi-analyte biosensor platform that continuously monitors biochemical markers such as glucose, lactate, ketones, cortisol, and kidney-related analytes from a single sensor.

Digital HealthHardwareMedical Devices

Katharina(CEO/Co-Founder)Matthew(CTO/Co-Founder)Gunter(CPO)

Breatheasy MIISTmiisttherapeutics.comin

Miist develops inhaled microparticle therapeutics that deliver medicine to the bloodstream in 30 seconds, targeting conditions like migraine, pain, and anxiety where rapid onset is critical.

BiotechDigital HealthHealthtechMedical DevicesAlameda, US

Eric Ezerins(Cofounder, Head of Technology)inDalton Signor(Cofounder, CEO)inRandy Krebs(Executive Officer)Jeffrey Schuster(Chief Technology Officer)inEvan Alfano(Director)

Co-investorsCAL InnovationCalifornia Innovation FundEntrepreneur FirstThe Innovation SpaceRefactor Capital

Capturacapturacorp.comin𝕏Jun 2026

Captura develops Direct Ocean Capture technology using bipolar membrane electrodialysis to remove CO₂ from the upper ocean and atmosphere.

CleantechClimate TechDeep TechPasadena, US

Chengxiang Xiang(Founder)Bernard David(Chairman of the Board of Directors)inHarry Atwater(Founder)inCX Xiang(Chief Technology Officer & Co-Founder)inSteve Oldham(Chief Executive Officer)in

BoardMichael Wheeler(Director)in

Co-investorsEni NextFuture Planet CapitalHitachi VenturesMaersk GrowthMOL SwitchTransLink Capital+3 more

Catena Biosciencescatenabio.comin

CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

Marco Lobba(Founder)inMatthew Francis(Founder)in

Co-investorsCalifornia Innovation FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Iaso VenturesJude GomilaLongeVC+14 more

Erg Bioergbio.comNov 2025 · $6.5M

Erg Bio converts waste biomass into fermentable sugars and intermediates for synthetic aviation fuels and chemicals, using an advanced solvent process and a proprietary yeast that produces enzymes and ferments sugars.

BiotechCleantechEnergyDublin, US

Vineet Rajgarhia(Co-founder & CEO)inBlake Simmons(Co-founder & CTO)inMichael Rabson(Co-founder & Strategic Advisor)in

Co-investorsAzolla VenturesJuniperLichen VenturesChevron Technology Ventures

Esperto Medicalesperto.healthin

Esperto Medical is a medical device company developing compact, sensor-based diagnostic and monitoring technology, drawing on expertise in electrical engineering, imaging, and machine learning.

AI & Machine LearningDigital HealthHealthtechMedical DevicesOrange County, US

Alaina Brinley Rajagopal(Founder)inAditya Rajagopal(Co-founder & CEO)inYaser Abu-Mostafa(Co-founder)Lynne Rollins(Chief Financial Officer)Raymond Jimenez(Chief Technology Officer)inJeff Stoll(Chief Product Officer)in

Co-investorsBold Capital PartnersCatalyst Health VenturesMaverick VenturesWavemaker Three-Sixty Health

H2Utechnologiesh2utechnologies.com

California Catalysts (Calicat) develops non-Iridium catalysts and stack components for hydrogen electrolyzers, using an AI model and a high-throughput discovery engine to identify catalyst materials that lower the levelized cost of hydrogen.

AI & Machine LearningCleantechNew MaterialsLos Angeles, US

Co-investorsYes VC

Holoclaraholoclara.comin𝕏

Holoclara develops therapeutics derived from symbiotic intestinal organisms (helminths) that modulate inflammation, metabolism, and tissue regeneration to address chronic disease, immune-related conditions, and aging.

BiotechHealthtechLongevity

Andrea Choe(CEO / Co-Founder)inPaul W. Sternberg(Co-Founder)inFrank C. Schroeder(Co-Founder)in

Co-investorsHorizons VenturesBold Capital PartnersEndurance28Kairos Venture Investments, LlcSV Latam Capital

Hydrosathydrosat.comin

Hydrosat converts satellite and ground data into actionable information for sustainable agriculture and water management.

AgTechAI & Machine LearningClimate TechData & InfrastructureSpace TechWashington, US

Pieter Fossel(CEO)inScott Alan Soenen(Executive Officer)Alan Royce Dalby(Executive Officer, Director)Yun Jin Kim(Executive Officer)

BoardAndrew Robert Dearing(Director)inAdam Niewinski(Director)in

Co-investorsBlue Bear Capital PartnersExpon CapitalHemisphere Ventures LLCIndustrious VenturesNextwave [X] PartnersOTB Ventures+7 more

Iambiciambic.aiin

Iambic develops AI technologies for drug discovery, using a high-throughput experimental platform to design small-molecule medicines and advance a pipeline of clinical candidates for cancers such as HER2-driven, breast, and ovarian tumors.

AI & Machine LearningBiotechDeep TechSan Diego, US

Tom Miller(Founder)inFred Manby(Founder)inChao Zhang(Executive Officer)inTabbert Teng(Executive Officer)Neil Josephson(Chief Medical Officer)inPete Olson(Chief Scientific Officer)in

Co-investorsAscenta CapitalAbingworthCatalio Capital ManagementAlumni VenturesCatalio Capital Management, LPCoatue Management+7 more

Imyooimyoo.healthin𝕏

ImYoo develops a platform that enables continuous, scalable biological data collection from patients outside traditional clinical settings to support precision medicine research and drug development.

BiotechDigital HealthHealthtech

Tatyana Dobreva(Founder)in

Co-investorsPsyMed Ventures

Izote Biosciencesizote.bioin

Izote is a fermentation technology company developing an anaerobic process for industrial biomanufacturing.

BiotechDeep TechNew MaterialsBerkeley, US

Victor Reyes-Umaña, PhD(Founder & CEO)

Co-investorsBee PartnersEmbark VenturesFTW VenturesJuniperRedstick VenturesCourtyard Ventures+1 more

Mangomangomicro.comin

Mango Micro makes the M6, an automated microbial colony counting system that uses machine learning to deliver CFU counts and digitize quality-control labs.

AI & Machine LearningHardwareHealthtech

Co-investorsRiot VenturesSoundproof VenturesBrick Mortar VenturesFirst Check VenturesGreat North VenturesIncisive Ventures

Membrionmembrion.comin

Membrion develops Electro-Ceramic Desalination (ECD) technology that treats complex industrial wastewater by continuously separating dissolved salts and metals, enabling water recovery and reuse without replacing existing infrastructure.

CleantechDeep TechNew MaterialsSeattle, US

Greg Newbloom(Founder & Chief Executive Officer)inThomas Mitchell(Executive Officer)inWayne Byrne(Executive Officer, Director)inJohn Plaza(Executive Officer, Director)inPhillip Pickett(Executive Officer, Director)

BoardNic Pannekeet(Director)in

Co-investorsE8 AngelsLam CapitalPangaea Ventures Us Inc.PureTerra VenturesSafar PartnersSand Hill Angels+2 more

Miticomitico.techDec 2024

Mitico develops a post-combustion carbon capture technology that collects and purifies carbon dioxide from flue gases at the source before it enters the atmosphere.

CleantechClimate TechDeep TechPasadena, US

Clement Cid(Executive Officer, Director)inAlan Yalun Gu(Director)

BoardVincent Brillault(Director)Edward Rubin(Director)

Co-investorsAP VenturesHalliburton LabsSOSV

Molecularinstrumentsmolecularinstruments.com

Molecular Instruments develops HCR (hybridization chain reaction) imaging products for enzyme-free, multiplex, quantitative in situ hybridization and immunofluorescence, enabling detection of RNA and protein targets.

BiotechDeep TechHardwareHealthtechMedical DevicesLos Angeles, US

Dr. Harry M.T. Choi(Founder & CEO)Prof. Niles A. Pierce(Founder & Chair of the Board)

Nuanced Healthnuancedhealth.comin

Nuanced Health develops healthcare solutions, though the specific product focus is not detailed on this team page.

AI & Machine LearningBiotechDeep TechHealthtechLos Angeles, US

Sarkis Mazmanian(Co-Founder)inYan Yang(Chief Scientific Officer)in

Co-investorsOpen Field CapitalAxial VC

PINCpinctech.comin

PINC develops nonlinear photonic circuits and devices based on periodically poled thin-film lithium niobate (NanoPPLN) technology for applications ranging from UV to mid-infrared wavelengths.

Deep TechHardwareNew MaterialsSemiconductors

Co-investorsQuantonationAccel-KKRQubits VenturesSutter Hill Ventures

Sift Biosciencessiftbio.cominNov 2025

Sift Biosciences develops T-cell immunotherapies for cancer and autoimmune diseases, using an AI-driven discovery platform combined with metagenomics and high-throughput cellular screening to identify microbially derived molecules that activate memory T cells.

AI & Machine LearningBiotechHealthtechSan Carlos, US

Yue Clare Lou(Co-Founder & CEO)in

BoardKevin Barrett(Director)inAltar Munis(Director)

Co-investorsEisai Innovation, Inc.SBI HoldingsFifty YearsLifespan Vision Ventures

Stroke Dxstroke-dx.comin𝕏

NeuraNova (formerly StrokeDx) develops non-invasive neurovascular diagnostic technology aimed at rapid detection for stroke and brain-related conditions.

Deep TechHealthtechMedical DevicesCulver City, US

Alexander Ballatori(Cofounder)Shane Shahrestani(Cofounder)in

Co-investorsDigiTx Partners LLC

Switch Therapeuticsswitchthera.comin

Switch Therapeutics develops RNA interference (RNAi) therapeutic applications targeting central nervous system diseases, leveraging research from Caltech, Harvard Medical School, and City of Hope.

AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US

Si-Ping Han(Secretary)inDeepshikha Datta(Chief Executive Officer and President)

BoardKevin Zhang(Director)Alicia Irurzun-Lafitte(Director)inDylan Morris(Director)in

Co-investorsBold Capital PartnersCRV (Charles River Ventures)Dolby Family VenturesGlobal BrainOno Venture Investment, Inc.Upfront Ventures+3 more

Tierra Biosciencestierrabiosciences.com

Tierra Biosciences develops high-performance protein design technology, serving biotechnology and pharmaceutical industries.

Biotech

Co-investorsBeresford VenturesCreative VenturesFifty YearsIn-Q-TelMaterial ImpactHumboldt+2 more

TippingPoint Biosciencestippingpointbiosciences.comin

TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer.

BiotechDeep TechHealthtechSan Francisco, US

Laura Hsieh(Founder & CEO)in

Co-investorsBrightEdgeEmpath VenturesSazzeSOSVStoryHouseXEIA Venture Partners

Vogentvogent.aiin𝕏Acquired

Vogent is a platform for building AI voice agents that can handle phone calls, powered by custom conversational models and text-to-speech technology.

AI & Machine LearningEnterprise SoftwareSaaSSan Francisco, US

Jagath Vytheeswaran(Founder)inVignesh Varadarajan(Founder)in

Co-investorsBlackbird VenturesXG VenturesY CombinatorGlobal Founders CapitalHydrocarbon Minerals 4Niche Capital+1 more

Wild Microbeswildmicrobes.comin

Wild Microbes uses synthetic biology to engineer microbes sourced from diverse wild biomes into production hosts for biomanufacturing high-performance ingredients.

BiotechDeep TechNew Materials

Timothy Wannier(Founder)in

Co-investorsAgronomicsCoalitionCollaborative FundJuniperSiddhi CapitalThird Derivative+2 more

ZeoDACzeodac.comin

ZeoDAC develops direct air capture (DAC) technology using zeolite-based materials to remove carbon dioxide from the atmosphere for climate mitigation and carbon management applications.

CleantechClimate TechDeep TechAtlanta, US

Mark E. Davis(Co-Founder and Executive Strategic Advisor)Christopher W. Jones(Co-Founder and Executive Strategic Advisor)in

Co-investorsAccelr8Global Brain

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

EquilibrFlion EnergyLaguna BioMiistNeuronovaPINC Technologies

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.